Unknown

Dataset Information

0

Homogeneous production and characterization of recombinant N-GlcNAc-protein in Pichia pastoris.


ABSTRACT: BACKGROUND:Therapeutic glycoproteins have occupied an extremely important position in the market of biopharmaceuticals. N-Glycosylation of protein drugs facilitates them to maintain optimal conformations and affect their structural stabilities, serum half-lives and biological efficiencies. Thus homogeneous N-glycoproteins with defined N-glycans are essential in their application in clinic therapeutics. However, there still remain several obstacles to acquire homogeneous N-glycans, such as the high production costs induced by the universal utilization of mammalian cell expression systems, the non-humanized N-glycan structures and the N-glycosylation microheterogeneities between batches. RESULTS:In this study, we constructed a Pichia pastoris (Komagataella phaffii) expression system producing truncated N-GlcNAc-modified recombinant proteins through introducing an ENGase isoform (Endo-T) which possesses powerful hydrolytic activities towards high-mannose type N-glycans. The results showed that the location of Endo-T in different subcellular fractions, such as Endoplasmic reticulum (ER), Golgi or cell membrane, affected their hydrolytic efficiencies. When the Endo-T was expressed in Golgi, the secreted IgG1-Fc region was efficiently produced with almost completely truncated N-glycans and the N-GlcNAc modification on the glycosite Asn297 was confirmed via Mass Spectrometry. CONCLUSION:This strategy develops a simple glycoengineered yeast expression system to produce N-GlcNAc modified proteins, which could be further extended to different N-glycan structures. This system would provide a prospective platform for mass production of increasing novel glycoprotein drugs.

SUBMITTER: Wang S 

PROVIDER: S-EPMC6956495 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Homogeneous production and characterization of recombinant N-GlcNAc-protein in Pichia pastoris.

Wang Shengjun S   Rong Yongheng Y   Wang Yaoguang Y   Kong Decai D   Wang Peng George PG   Chen Min M   Kong Yun Y  

Microbial cell factories 20200113 1


<h4>Background</h4>Therapeutic glycoproteins have occupied an extremely important position in the market of biopharmaceuticals. N-Glycosylation of protein drugs facilitates them to maintain optimal conformations and affect their structural stabilities, serum half-lives and biological efficiencies. Thus homogeneous N-glycoproteins with defined N-glycans are essential in their application in clinic therapeutics. However, there still remain several obstacles to acquire homogeneous N-glycans, such a  ...[more]

Similar Datasets

| S-EPMC8585081 | biostudies-literature
| S-EPMC8037066 | biostudies-literature
| S-EPMC4094982 | biostudies-literature
| S-EPMC4909809 | biostudies-literature
| S-EPMC5470459 | biostudies-literature
| S-EPMC5976186 | biostudies-literature
| S-EPMC4585289 | biostudies-literature
| S-EPMC6751620 | biostudies-literature
| S-EPMC8313290 | biostudies-literature
| S-EPMC2635529 | biostudies-literature